In Case You Missed It – Updates
August 18, 2015; Posted by: WeBleed staff
Check out these updates about pharmaceuticals, meetings, conferences, and informational articles.
These are the articles and topics that trending today in the world of bleeding and clotting disorders. Check out the summaries of each and read the original articles by clicking the links:
— Biogen (BIIB) Issues Positive Update on ALPROLIX Phase 3 in Severe Hemophilia B – StreetInsider.com reports that new clinical data supports the long-term safety and efficacy of ALPROLIX in people with severe hemophilia B treated for up to two years.
— MicroHealth Helps Patients Manage Chronic Illnesses – TechCrunch reports that through a disease management and doctor communication platform, MicroHealth is attempting to crowdsource the management of rare, chronic conditions, starting with hemophilia.
— Heavy Periods? – Lisa McNiven of The Sherwood Park News reports on a lesser known term and blood disorder called menorrhagia.
— Astronaut Dr. Mae Jemison and Bayer Bring Science Education Message to Hemophilia Patients at NHF Event – SYS-CON Media reports that Bayer HealthCare recently had a dinner event at the National Hemophilia Foundation’s 67th Annual Meeting in Dallas, Texas, featuring a keynote address from Dr. Mae Jemison, the first African-American woman astronaut, who shared her love of exploration, meeting challenges and growing up.
